A California-based genetic testing manufacturer plans to create 242 jobs when it builds a clinical laboratory in Research Triangle Park to develop a screening test to determine whether fetuses have Down Syndrome.
Gov. Beverly Perdue announced Wednesday that Sequenom Inc. would invest $19 million in the lab during an event at the North Carolina Biotechnology Center.
The company is preparing to launch in the coming months the noninvasive prenatal screening test for trisomy 21, the most common cause of Down Syndrome.
Perdue's office said the average salary for the new jobs will be nearly $54,000.
A state committee agreed earlier Wednesday to offer incentives to Sequenom to build their molecular diagnostics lab. The company could receive up to $2.3 million from the state if it meets employment and investment targets.